Cargando…

Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study

PURPOSE: This study aimed to investigate difficulties doctors experience during life-sustaining treatment (LST) discussion with seriously ill patients and their families after enactment of the LST Decisions Act in February 2018. MATERIALS AND METHODS: A cross-sectional survey was conducted in a tert...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Shin Hye, Choi, Wonho, Kim, Yejin, Kim, Min Sun, Park, Hye Yoon, Keam, Bhumsuk, Heo, Dae Seog
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053877/ https://www.ncbi.nlm.nih.gov/pubmed/33211941 http://dx.doi.org/10.4143/crt.2020.735

Ejemplares similares

Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients
por: Kim, Jung Sun, et al.
Publicado: (2020)

Problems Related to the Act on Decisions on Life-Sustaining Treatment and Directions for Improvement
por: Heo, Dae Seog, et al.
Publicado: (2022)

Ethical Issues Referred to Clinical Ethics Support at a University Hospital in Korea: Three-Year Experience After Enforcement of Life-Sustaining Treatment Decisions Act
por: Yoo, Shin Hye, et al.
Publicado: (2023)

Current Status and Cardinal Features of Patient Autonomy after Enactment of the Life-Sustaining Treatment Decisions Act in Korea
por: Kim, Hwa Jung, et al.
Publicado: (2021)

Experiences and Opinions Related to End-of-Life Discussion: From Oncologists' and Resident Physicians' Perspectives
por: Koh, Su-Jin, et al.
Publicado: (2018)

Aggressiveness of care in the last days of life in the emergency department of a tertiary hospital in Korea
por: Kim, Jung Sun, et al.
Publicado: (2022)

Life-Sustaining Medical Treatment for Terminal Patients in Korea
por: Heo, Dae Seog
Publicado: (2013)

Life-Sustaining Treatment States in Korean Cancer Patients after Enforcement of Act on Decisions on Life-Sustaining Treatment for Patients at the End of Life
por: Won, Young-Woong, et al.
Publicado: (2021)

The Situation of Life-Sustaining Treatment One Year after Enforcement of the Act on Decisions on Life-Sustaining Treatment for Patients at the End-of-Life in Korea: Data of National Agency for Management of Life-Sustaining Treatment
por: Lee, Ha Yeon, et al.
Publicado: (2021)

Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea
por: Kim, Dalyong, et al.
Publicado: (2022)

The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer
por: Yoo, Shin Hye, et al.
Publicado: (2018)

Practical Considerations in Providing End-of-Life Care for Dying Patients and Their Family in the Era of COVID-19
por: Kim, Yejin, et al.
Publicado: (2021)

Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute
por: Choi, Younak, et al.
Publicado: (2015)

Use of high‐flow nasal cannula oxygen therapy for patients with terminal cancer at the end of life
por: Kim, Jung Sun, et al.
Publicado: (2023)

Barriers to Counseling on Advance Directives Based on Counselors’ Experiences: Focus Group Interviews
por: Kim, Yejin, et al.
Publicado: (2020)

Preparation and Practice of the Necessary Documents in Hospital for the “Act on Decision of Life-Sustaining Treatment for Patients at the End-of-Life”
por: Baek, Sun Kyung, et al.
Publicado: (2021)

Impact of COVID-19 on the End-of-Life Care of Cancer Patients Who Died in a Korean Tertiary Hospital: A Retrospective Study
por: Shin, Jeongmi, et al.
Publicado: (2022)

Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act
por: Kim, Hyeyeong, et al.
Publicado: (2021)

Awareness of Doctors’ Shared Decision-Making in Life-Sustaining Care Decisions
por: Kim, Dalyong, et al.
Publicado: (2021)

Trends in Nursing Research on Life-Sustaining Treatment in South Korea after the Enforcement of the Act on Decisions on Life-Sustaining Treatment
por: Choi, Jun-Hwa, et al.
Publicado: (2022)

Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer
por: Yoo, Shin Hye, et al.
Publicado: (2018)

Hospice-Palliative Medicine as a Model of Value-Based Healthcare
por: Heo, Dae Seog, et al.
Publicado: (2022)

Challenges in Care for Non-COVID-19 Patients with Severe Chronic Illnesses during COVID-19 Pandemic: A Qualitative Study of Healthcare Providers Working around Acute Care Hospitals in South Korea
por: Kim, Yejin, et al.
Publicado: (2023)

Comparison of the end-of-life decisions of patients with hospital-acquired pneumonia after the enforcement of the life-sustaining treatment decision act in Korea
por: Baek, Ae-Rin, et al.
Publicado: (2023)

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment
por: Oh, So Yeon, et al.
Publicado: (2021)

End-of-life discussions reduce the utilization of life-sustaining treatments during the last three months of life in cancer patients
por: Chan, Shang-Yih, et al.
Publicado: (2022)

Decision and Practice of End-of-Life Care in Lung Disease Patients with Physicians Orders for Life Sustaining Treatment
por: Oh, Yu Mi, et al.
Publicado: (2023)

Housestaff perceptions on training and discussing the Maryland Orders for Life Sustaining Treatment Form (MOLST)
por: Zaeh, Sandra E., et al.
Publicado: (2020)

Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
por: Cho, Kyoung Min, et al.
Publicado: (2015)

Exploring the experiences and perspectives of emergency physicians on brain death organ tissue donation after the Life-Sustaining Treatment Decision Act
por: Park, Song Yi, et al.
Publicado: (2022)

Will implementation of the Life-Sustaining Treatment Decisions Act reduce the incidence of cardiopulmonary resuscitation?
por: Song, In-Ae
Publicado: (2022)

The Future Direction of the Organ Donation System After Legislation of the Life-Sustaining Treatment Decision Act
por: Baik, Seung Min, et al.
Publicado: (2021)

Experience and perspectives of end-of-life care discussion and physician orders for life-sustaining treatment of Korea (POLST-K): a cross-sectional study
por: Im, Hyeon-Su, et al.
Publicado: (2023)

The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer
por: Lee, June-Koo, et al.
Publicado: (2015)

Hemodialysis as a life-sustaining treatment at the end of life
por: Shin, Sung Joon, et al.
Publicado: (2018)

Discussions and Implications of the Recent Enactment & Revision of the Healthcare Law
por: Kwon, Oh-Tak, et al.
Publicado: (2012)

KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
por: Park, Sehhoon, et al.
Publicado: (2017)

Mediating Effects of Role Perception of Life-sustaining Treatment in the Relationship between Knowledge of Life-sustaining Treatment Plans and Attitudes toward Withdrawal of Life-sustaining Treatment among Nursing College Students
por: Park, Youngmi, et al.
Publicado: (2021)

Changes in the incidence of cardiopulmonary resuscitation before and after implementation of the Life-Sustaining Treatment Decisions Act
por: Im, Hyunjae, et al.
Publicado: (2022)

Discussing patient preferences for levels of life-sustaining treatment: development and pilot testing of a Danish POLST form
por: Tuesen, Lone Doris, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0oensoic44p7ipj6fdub44jfjq